BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
June 9, 2004
View Archived Issues
IDM Seeking EUR92 Million In IPO To Fund Programs In Cancer
PARIS - Immuno-Designed Molecules SA proposed an IPO on the Nouveau Marche of the Euronext stock exchange in Paris last week, offering 8.1 million shares at €10.50 to €12.20 per share. (BioWorld International)
Read More
UK Researchers Discover Mutant Gene's Role In Type II Diabetes
Read More
Countries Throughout The World Promoting Biotech Development
Read More
UK Officials Continue Campaign To Improve Biotech Environment
Read More
Serono Abandons Emfilermiun, Setting Back Amrad Program
Read More
Private Australian Companies Cerylid, Kinacia Merge Efforts
Read More
IQ Corp., U.S. Navy Enter Deal To Develop Biodefense Agents
Read More
Shareholders Accept Deal To Close Shop At PPL Therapeutics
Read More
Other News To Note
Read More